Aligos Therapeutics (ALGS) Non-Current Assets (2019 - 2026)
Aligos Therapeutics (ALGS) reported Non-Current Assets of $4.2 million for Q2 2026, down 37.9% from $6.76 million a year earlier and down 14.8% from the prior quarter.
Powered by 
Analysis
Aligos Therapeutics (ALGS) Non-Current Assets (2019 - 2026) Analysis & Trends
At the end of FY2025, Aligos Therapeutics posted Non-Current Assets of $5.67 million, down 28.7% from FY2024.
- Non-Current Assets has declined for four consecutive years, with a five-year compound annual growth rate of -18.0% (FY2020 to FY2025).
- By year, Non-Current Assets came in at $7.95 million in FY2024 (-23.8%), $10.44 million in FY2023 (-20.6%), $13.15 million in FY2022 (-57.5%) and $30.95 million in FY2021 (+102.5%).
- The Q2 2026 figure ranks as the lowest quarterly Non-Current Assets in data going back to Q4 2019.
- Year over year, Non-Current Assets has now declined in each of the last 17 quarters, with an average decline of 28.1% over the last eight quarters.
- The high point for year-over-year Non-Current Assets in five years was Q4 2021 (growth of 102.5%); the low point was Q4 2022 (a decline of 57.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $4.93 million (Q1 2026), $5.67 million (Q4 2025) and $6.33 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,140.41 Bn | 1,108.99 Bn | 19.71 Bn | 77.61 Bn |
| 2 | Johnson & Johnson | 618.57 Bn | 537.10 Bn | 17.26 Bn | 141.29 Bn |
| 3 | AbbVie | 509.95 Bn | 483.06 Bn | 12.70 Bn | 101.45 Bn |
| 4 | Merck | 366.63 Bn | 321.01 Bn | 12.21 Bn | 125.00 Mn |
| 5 | Novartis Ag | 298.47 Bn | 262.46 Bn | 11.24 Bn | 94.68 Bn |
| 6 | Astrazeneca | 263.21 Bn | 236.89 Bn | 12.86 Bn | 87.87 Bn |
| 7 | Amgen | 236.71 Bn | 192.11 Bn | 7.24 Bn | 60.68 Bn |
| 8 | Gilead Sciences | 193.05 Bn | 167.25 Bn | 6.22 Bn | 35.42 Bn |
| 9 | Pfizer | 171.45 Bn | 118.10 Bn | 10.94 Bn | 159.77 Bn |
| 10 | Aligos Therapeutics | 52.52 Mn | -275.89 Mn | - | 4.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.20 Mn |
| Mar 31, 2026 | 4.93 Mn |
| Dec 31, 2025 | 5.67 Mn |
| Sep 30, 2025 | 6.33 Mn |
| Jun 30, 2025 | 6.76 Mn |
| Mar 31, 2025 | 7.49 Mn |
| Dec 31, 2024 | 7.95 Mn |
| Sep 30, 2024 | 8.60 Mn |
| Jun 30, 2024 | 9.24 Mn |
| Mar 31, 2024 | 9.84 Mn |
| Dec 31, 2023 | 10.44 Mn |
| Sep 30, 2023 | 11.21 Mn |
| Jun 30, 2023 | 11.89 Mn |
| Mar 31, 2023 | 12.31 Mn |
| Dec 31, 2022 | 13.15 Mn |
| Sep 30, 2022 | 13.98 Mn |
| Jun 30, 2022 | 14.84 Mn |
| Mar 31, 2022 | 15.39 Mn |
| Dec 31, 2021 | 30.95 Mn |
| Sep 30, 2021 | 14.40 Mn |
API Access
Aligos Therapeutics Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=ALGS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "ALGS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=ALGS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();